Zip, ah, okay...makes sense but I still think the SPA reinstatement and (conditional) approval of Anchor makes Vascepa an attractive acquisition target for BP which will help drive up the price. In the husband and wife scenario, it's the wife who invested (me) and has to explain to husband that I am not crazy, that it really will pay off in the end. :)
Hey zip: that was my downfall, my 401k has a Self directed feature (SDA) essentially an IRA. Run by Fidelity, they allowed me to buy AMRN @ $5, I'm out of money so I can't test your theory but I am able to buy penny stocks. This is a great buying opp. Of course last week was even better.
Market Data 
Markets 
AI
